TipRanks
Go Ultimate55% OFF

John T. Treace Insider Profile

11 Followers

John T. Treace, CEO, Director, Ten Percent Owner at Treace Medical Concepts, holds 12.73M shares in Treace Medical Concepts (Ticker: TMCI). Most recently, John T. Treace Bought 55,944 shares of Treace Medical Concepts on Aug 24, 2026 for an estimated value of $246.28K.

John T. Treace's Trading History

TMCI
Treace Medical Concepts
Aug 24, 2026CEO, Director, Ten Percent OwnerInformative Buy246.28K$56.39M
TMCI
Insider Shares: 12.73M (19.57%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 24, 2026Informative Buy$246.28K55,944$4.40+1.30%
Jun 11, 2026Informative Buy$210.77K52,317$4.02+13.20%
Jun 01, 2026Informative Buy$177.50K50,000$3.55+23.00%
May 28, 2026Informative Buy$339.70K115,520$2.94+43.80%
May 14, 2026Informative Buy$374.56K153,763$2.43+59.90%

You May Also Like

John T. Treace insider profile FAQ

What is the percentage of profitable transactions made by John T. Treace?
The percentage of profitable transactions made by John T. Treace is 95%.
What is the average return per transaction made by John T. Treace?
The average return per transaction made by John T. Treace is 21.20%.
What stocks does John T. Treace hold?
John T. Treace holds: TMCI stocks.
What was John T. Treace’s latest transaction?
John T. Treace’s latest transaction was an Informative Buy of $246.28K.
What was John T. Treace's most profitable transaction?
John T. Treace’s most profitable transaction was an Informative Buy of TMCI stock on May 14, 2026. The return on the trade was 59.90%.
What is John T. Treace's role in Treace Medical Concepts?
John T. Treace's role in Treace Medical Concepts is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.